FDA rejects 2 HIV drugs from Gilead Sciences

FDA rejects 2 HIV drugs from Gilead Sciences - The Times and Democrat

South Africa Standard Time — Wednesday, May 01, 2013

FDA rejects 2 HIV drugs from Gilead Sciences - The Times and Democrat

The FDA informed the company in a letter that it cannot approve its HIV pills elvitegravir and cobicistat for use in managing the virus that causes AIDS. The agency noted that in recent inspections, regulators have found problems with documentations ...

Stigmabase | HIV

FDA rejects 2 HIV drugs from Gilead Sciences - The Times and Democrat

FDA rejects 2 HIV drugs from Gilead Sciences - The Times and Democrat

Top stories of the last 30 days

Study highlights importance of early interventions to combat HIV

Indigenous organization asking feds for $20 million to help control HIV crisis

Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health equity'

Prioritising post-testing healthcare needs of the secretive, reclusive

Cognitive impairment in children and adolescents living with perinatal HIV disease in the ART era

Congo Republic declares mpox epidemic

Egypt records first case of mpox

Cognitive Impairment Still Seen in Children, Teens With HIV